"The Universal Flu Shot Moves Within Reach"
Long promised, a lifelong vaccine for every form of influenza has entered human trials. Peter Palese, PhD, professor and chair of microbiology at the Icahn School of Medicine at Mount Sinai and his colleagues are developing a universal flu vaccine that, he says, “would protect against all different variants of the influenza virus, and would offer long-lasting or even lifelong protection.” Adolfo Garcia-Sastre, PhD, director of the Global Health and Emerging Pathogens Institute and professor of microbiology, medicine and infectious diseases at the Icahn School of Medicine at Mount Sinai says, “The impact of a universal influenza virus vaccine will be enormous. Influenza is one of the biggest killers in the world, taking between 291,000 and 646,000 lives a year, and during pandemic years, it is even worse. A universal flu vaccine could reduce the huge costs associated with responding to and treating influenza; and most importantly, it could save millions of lives.”
- Peter Palese, PhD, Professor, Chair, Microbiology, Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai
- Adolfo Garcia-Sastre, PhD, Director, Global Health and Emerging Pathogens Institute, Professor, Microbiology, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai
- Florian Krammer, PhD, Associate Professor, Microbiology, Icahn School of Medicine at Mount Sinai
